Transcatheter Aortic Valve Implantation: Current and Evolving Indications

Altayyeb Yousef; Michael Froeschl; Benjamin Hibbert; Ian G Burwash; Marino Labinaz

doi:10.1016/j.cjca.2015.04.033

Transcatheter Aortic Valve Implantation: Current and Evolving Indications

Can J Cardiol. 2016 Feb;32(2):266-9. doi: 10.1016/j.cjca.2015.04.033. Epub 2015 Jun 14.

Authors

Altayyeb Yousef¹, Michael Froeschl¹, Benjamin Hibbert¹, Ian G Burwash¹, Marino Labinaz²

Affiliations

¹ Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
² Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada. Electronic address: mlabinaz@ottawaheart.ca.

PMID: 26481084
DOI: 10.1016/j.cjca.2015.04.033

Abstract

Transcatheter Aortic Valve Implantation (TAVI) was initially developed to treat aortic stenosis in patients with high risk for surgical intervention. With great initial adoption of the technology and improvements in device design and procedural success TAVI is increasingly being performed in broader populations for diverse indications. This paper is a concise review of the evolving and expanding use of TAVI in the current era.

Publication types

Review

MeSH terms

Aortic Valve Stenosis / diagnosis
Aortic Valve Stenosis / surgery*
Equipment Design
Humans
Severity of Illness Index
Transcatheter Aortic Valve Replacement / instrumentation*
Treatment Outcome